Rosuvastatin Completed Phase 1 Trials for Hyperlipidemias / High Blood Pressure (Hypertension) Treatment

Back to Rosuvastatin
IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03116516Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin
NCT02075619Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
NCT01609907Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan
NCT01918358Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
NCT02047175CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
NCT02387619The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
NCT02569814A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
NCT02951962A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin
NCT03009474Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers